Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

Journal of hepatology - 1 Feb 2013

Zeisel Mirjam B, Lupberger Joachim, Fofana Isabel, Baumert Thomas F

Abstract excerpt

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and hepatocellular carcinoma worldwide. Furthermore, HCV-induced liver disease is a major indication of liver transplantation. In the past years, direct-acting antivirals (DAAs) targeting HCV enzymes have been developed....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Treatment Outcome

Source

Identifiers

PMID: 23041307
DOI: 10.1016/j.jhep.2012.09.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23041307-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.PMID 23041307Read ↗

Host-targeting agents in the treatment of hepatitis C: A beginning and an end?Semantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

What are the pros and cons of the use of host-targeted agents against hepatitis C?Semantic proximity Read ↗

Current and emerging therapeutic approaches to hepatitis C infection.Semantic proximity Read ↗

Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapySemantic proximity Read ↗

Current therapy for chronic hepatitis C: The role of direct-acting antivirals.Semantic proximity Read ↗

Novel therapies for hepatitis C - one pill fits all?Semantic proximity Read ↗

Hepatitis C virus—biology, host evasion strategies, and promising new therapies on the horizonSemantic proximity Read ↗

Hepatitis C Virus Therapies: Current Treatments, Targets and Future PerspectivesSemantic proximity Read ↗

Direct-acting antivirals: the endgame for hepatitis C?Semantic proximity Read ↗

The new era of hepatitis C virus therapy.Semantic proximity Read ↗

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.